Rui de Passos Sousa

Caplacizumab Model‐Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura

F. Callewaert, M. Bergstrand, Emma K. Hansson, 2021, Journal of clinical pharmacology.

Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study

P. Knöbl, P. Coppo, F. Peyvandi, 2022, Journal of thrombosis and haemostasis : JTH.

Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune‐mediated thrombotic thrombocytopenic purpura in the United States

A. Adeyemi, Rui de Passos Sousa, Francesca Razakariasa, 2022, Research and practice in thrombosis and haemostasis.